A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/506 (2006.01) A61K 31/197 (2006.01) A61K 31/5377 (2006.01) A61K 31/635 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2614088
The present invention relates to the use of compounds for producing a pharmaceutical product/medicament for the prophylaxis and/or treatment of reperfusion damage.
La présente invention concerne l'utilisation de la production d'un produit pharmaceutique/médicament pour la prévention et/ou le traitement des dommages de reperfusion.
Krahn Thomas
Stasch Johannes-Peter
Thielemann Wolfgang
Weimann Gerrit
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Use of soluble guanylate cyclase activators for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of soluble guanylate cyclase activators for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of soluble guanylate cyclase activators for treating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1578031